SOLVAY FINALIZES AGREEMENT TO BUY FOURNIER PHARMA

Solvay announced it has signed a final purchase agreement with the shareholders of Fournier Pharma for the acquisition of 100% of the company. Substantial social and regulatory procedures have been successfully completed worldwide. The transaction, which now only awaits approval from the European and some national competition authorities, should be finalized this summer, as previously announced. The final terms of the transaction include an initial upfront cash payment of EUR 1.2 billion, instead of the previously announced figure of EUR 1.3 billion.

PharmaLive (http://www.medadnews.com/News/index.cfm?articleid=255277)